Filter zurücksetzen
Stichworte
Mammatumoren, Mensch ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
    1. 1.1. Ein-/Ausschluss
    1. 1.2. Anamnese
    1. 1.3. Körperliche Untersuchung
    1. 1.4. Score
    1. 1.5. Apparative Diagnostik
    1. 1.6. Labor
    1. 1.7. Pathologie/Histologie
    1. 1.8. Aufklärung/Einverständis
    1. 1.9. Therapie
    1. 1.10. Operationsbericht
    1. 1.11. Unerwünschtes Ereignis
    1. 1.12. Follow-Up
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

1642 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Breast Cancer NCT00433589 Treatment - Endocrine therapy - 2498727v1.0 - Endocrine therapy

- 09.01.15 - 1 Formular, 3 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Header, Endocrine therapy, Footer Module
Endocrine therapy Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=19677A9A-FFBD-2E6F-E044-0003BA3F9857

Breast Cancer Adverse Event NCT00382070 - rade 2 and 3 Adverse Event Report Breast Cancer NCT00382070 NSABP B-42

- 20.09.21 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Header, Adverse event
NSABP Protocol B-42 - Grade 2 and 3 Adverse Event (AE) Report Form Worksheet Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer NCT00382070 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17ADF05F-DB75-341D-E044-0003BA3F9857

Breast Cancer Registration SWOG NCT00070564 - REGISTRATION Breast Cancer NCT00070564

- 17.11.21 - 1 Formular, 3 Itemgruppen, 26 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient characteristics, Patient Consent For Specimen Use
SOUTHWEST ONCOLOGY GROUP REGISTRATION FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer NCT00070564 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A678842F-926F-5086-E034-0003BA0B1A09

Eligibility Sarcopenic Obesity in Breast Cancer Survival NCT01843608

- 28.09.21 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Effect of Combined Exercise Post-treatment Intervention in Lean Mass Recovery in Breast Cancer Survival.; ODM derived from: https://clinicaltrials.gov/show/NCT01843608

Breast Cancer Registration SWOG S0226 NCT00075764 - Registration Breast Cancer NCT00075764

- 27.09.21 - 1 Formular, 3 Itemgruppen, 39 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient data, Consent
Southwest Oncology Group Registration Form (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7

Breast Cancer NCT01101438 Follow-Up - NCIC MA.32 Telephone Follow-Up Report - 3025096v1.0 - NCIC MA.32 Telephone Follow-Up Report

- 27.09.21 - 1 Formular, 5 Itemgruppen, 17 Datenelemente, 1 Sprache
Itemgruppen: TIMING OF REPORT - TELEPHONE FOLLOW-UP, METFORMIN/PLACEBO ADMINISTRATION, SERIOUS ADVERSE EVENT - QUESTION, ADVERSE EVENTS ON TREATMENT - QUESTION, ADVERSE EVENTS
NCIC MA.32 Telephone Follow-Up Report A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=81DC7457-3943-EA84-E040-BB89AD43055B

Eligibility NCT01250379 Breast Cancer - Eligibility

- 27.09.21 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01250379

Eligibility NCT01238029 Metastatic Breast Cancer - Eligibility

- 27.09.21 - 1 Formular, 2 Itemgruppen, 26 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01238029

Eligibility DRKS00007744 NCT01026142 Breast Cancer - Eligibility

- 27.09.21 - 1 Formular, 2 Itemgruppen, 17 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01026142

Eligibility Breast Cancer NCT00818051

- 27.09.21 - 1 Formular, 1 Itemgruppe, 20 Datenelemente, 1 Sprache
Itemgruppe: Criteria
Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00818051

Eligibility Metastatic Breast Cancer NCT01044485

- 27.09.21 - 1 Formular, 2 Itemgruppen, 20 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01044485

Eligibility Metastatic Breast Cancer NCT02394496

- 27.09.21 - 1 Formular, 2 Itemgruppen, 28 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Overcoming Endocrine Resistance in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02394496

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video